Relx (LON:REL) Rating Reiterated by Morgan Stanley

Relx (LON:RELGet Rating)‘s stock had its “overweight” rating reiterated by equities research analysts at Morgan Stanley in a research report issued on Wednesday, Digital Look reports.

REL has been the subject of several other reports. Credit Suisse Group set a GBX 2,650 ($32.67) target price on shares of Relx in a report on Tuesday, April 19th. UBS Group set a GBX 2,615 ($32.24) price target on shares of Relx in a research report on Wednesday, March 2nd. JPMorgan Chase & Co. set a GBX 2,670 ($32.92) target price on shares of Relx in a research report on Thursday, April 21st. Berenberg Bank upped their target price on shares of Relx from GBX 2,300 ($28.36) to GBX 2,330 ($28.73) and gave the stock a “hold” rating in a research report on Friday, February 11th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Relx in a research note on Tuesday, February 8th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of GBX 2,440.42 ($30.09).

Shares of REL opened at GBX 2,300.34 ($28.36) on Wednesday. The firm’s 50-day moving average price is GBX 2,338.24 and its 200-day moving average price is GBX 2,317.55. The firm has a market capitalization of £44.33 billion and a price-to-earnings ratio of 30.35. The company has a current ratio of 0.63, a quick ratio of 0.47 and a debt-to-equity ratio of 191.50. Relx has a 1-year low of GBX 1,781 ($21.96) and a 1-year high of GBX 2,474 ($30.50).

In other news, insider N L. Luff sold 13,867 shares of the stock in a transaction on Friday, February 11th. The shares were sold at an average price of GBX 2,273 ($28.02), for a total value of £315,196.91 ($388,604.25).

About Relx (Get Rating)

RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.

Further Reading

Analyst Recommendations for Relx (LON:REL)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.